Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Shares, par value (euro)0.12 per share
-
Shares outstanding
-
22.4M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
14.6M
-
Shares change
-
+909K
-
Total reported value, excl. options
-
$503M
-
Value change
-
+$22.4M
-
Put/Call ratio
-
1.85
-
Number of buys
-
61
-
Number of sells
-
-51
-
Price
-
$34.31
Significant Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) as of Q4 2021
156 filings reported holding CVAC - CureVac N.V. - Common Shares, par value (euro)0.12 per share as of Q4 2021.
CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.6M shares
of 22.4M outstanding shares and own 65.34% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (3.92M shares), Bill & Melinda Gates Foundation (3.13M shares), BlackRock Inc. (1.8M shares), STATE STREET CORP (603K shares), PRICE T ROWE ASSOCIATES INC /MD/ (504K shares), NORGES BANK (473K shares), GOLDMAN SACHS GROUP INC (343K shares), GEODE CAPITAL MANAGEMENT, LLC (302K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (253K shares), and VOLORIDGE INVESTMENT MANAGEMENT, LLC (233K shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.